Finnadvance

Finnadvance is bridging the gap between in-vitro and in-vivo research with its microfluidic organ-on-chips for pharmaceutical drug research and development. With industry leading high throughput microphysiological culture platforms, complex in vivo biomechanical cues are mimicked on the in vitro cultures.

 

    • Founding year: 
2019

    • Development phase:
Market-ready

    • Funding stage:
A round

    • Website: 
Finnadvance

    • Contact person info: 
science(at)finnadvance.com

    • Team members: 
18

    • Article:
Read an article about Finnadvance.